Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome
D. Paran(Tel Aviv Sourasky Medical Center), Bella Koifman, David Levartovsky(University Medical Center), Irena Litinsky(Tel Aviv University), Dan Caspi(Tel Aviv University), Ilana Kaufman(Tel Aviv University), Ori Elkayam(Tel Aviv University), Gad Keren(Assuta Medical Center)
Cited by 41
Related Papers
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
|Journal of the American College of Cardiology|2000|731
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
|Journal of the American College of Cardiology|2001|646
Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography
|Atherosclerosis|2012|390
Role of Naturally Occurring CD4 <sup>+</sup> CD25 <sup>+</sup> Regulatory T Cells in Experimental Atherosclerosis
|Arteriosclerosis Thrombosis and Vascular Biology|2007|347